Bernitsas advised Lavipharm on the deal. Lavipharm executed a €51.2 million equity capital raising and listing of their new shares on the Athens Exchange. Lavipharm is a leading pharmaceutical company...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here